Monoclonal Antibody Treatment Market Report

Global and Region Monoclonal Antibody Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：158
  • REPORT CODE：GMM970983
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Monoclonal Antibody Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Monoclonal Antibody Treatmentmarket, defines the market attractiveness level of Monoclonal Antibody Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Monoclonal Antibody Treatment industry, describes the types of Monoclonal Antibody Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Monoclonal Antibody Treatment market and the development prospects and opportunities of Monoclonal Antibody Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Monoclonal Antibody Treatment market in Chapter 13.

    By Player:

    • Roche

    • Merck

    • AbbVie

    • Sanofi

    • GlaxoSmithKline

    • Pfizer

    • Bayer

    • Novartis

    By Type:

    • Cancer

    • Autoimmune Diseases

    • Infection

    • Hematological Diseases

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Monoclonal Antibody Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Monoclonal Antibody Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Monoclonal Antibody Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Monoclonal Antibody Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Monoclonal Antibody Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.2 United States Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.3 Europe Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.4 China Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.5 Japan Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.6 India Monoclonal Antibody Treatment Consumption (2017-2022)

    • 7.7 South Korea Monoclonal Antibody Treatment Consumption (2017-2022)

    8 Region and Country-wise Monoclonal Antibody Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.4 China Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.6 India Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Monoclonal Antibody Treatment Consumption Forecast (2022-2028)

    9 Global Monoclonal Antibody Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Monoclonal Antibody Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Infection Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Hematological Diseases Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Monoclonal Antibody Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Monoclonal Antibody Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Monoclonal Antibody Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Hematological Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Monoclonal Antibody Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Monoclonal Antibody Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Monoclonal Antibody Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Monoclonal Antibody Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Monoclonal Antibody Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Monoclonal Antibody Treatment Market Competitive Analysis

    • 14.1 Roche

      • 14.1.1 Roche Company Details

      • 14.1.2 Roche Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Roche Monoclonal Antibody Treatment Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Monoclonal Antibody Treatment Product and Service

    • 14.3 AbbVie

      • 14.3.1 AbbVie Company Details

      • 14.3.2 AbbVie Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AbbVie Monoclonal Antibody Treatment Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Monoclonal Antibody Treatment Product and Service

    • 14.5 GlaxoSmithKline

      • 14.5.1 GlaxoSmithKline Company Details

      • 14.5.2 GlaxoSmithKline Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Monoclonal Antibody Treatment Product and Service

    • 14.7 Bayer

      • 14.7.1 Bayer Company Details

      • 14.7.2 Bayer Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bayer Monoclonal Antibody Treatment Product and Service

    • 14.8 Novartis

      • 14.8.1 Novartis Company Details

      • 14.8.2 Novartis Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis Monoclonal Antibody Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Monoclonal Antibody Treatment

    • Figure Monoclonal Antibody Treatment Picture

    • Table Global Monoclonal Antibody Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Monoclonal Antibody Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Monoclonal Antibody Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Monoclonal Antibody Treatment Consumption by Country (2017-2022)

    • Figure United States Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Monoclonal Antibody Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibody Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Monoclonal Antibody Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Hematological Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hematological Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Monoclonal Antibody Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Monoclonal Antibody Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Monoclonal Antibody Treatment Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Monoclonal Antibody Treatment Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Monoclonal Antibody Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Monoclonal Antibody Treatment Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Monoclonal Antibody Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Monoclonal Antibody Treatment Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Monoclonal Antibody Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Monoclonal Antibody Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Monoclonal Antibody Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US